Get the Stockscreener App
24.01
0.91%
-0.22
After Hours:
23.07
-0.94
-3.92%
Omada Health Inc stock is traded at $24.01, with a volume of 324.22K.
It is down -0.91% in the last 24 hours and up +11.26% over the past month.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
See More
Previous Close:
$24.23
Open:
$24.56
24h Volume:
324.22K
Relative Volume:
0.71
Market Cap:
$1.38B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+9.68%
1M Performance:
+11.26%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$23.30
$24.60
1-Week Range:
$22.08
$25.28
52-Week Range:
$14.14
$25.28
Omada Health Inc Stock (OMDA) Company Profile
Name
Omada Health Inc
Sector
Industry
Phone
888-987-8337
Address
500 SANSOME STREET, SAN FRANCISCO
Compare OMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMDA
Omada Health Inc
|
24.01 | 1.40B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-05-25 | Initiated | Robert W. Baird | Neutral |
| Jul-01-25 | Initiated | Barclays | Overweight |
| Jul-01-25 | Initiated | Canaccord Genuity | Buy |
| Jul-01-25 | Initiated | Evercore ISI | Outperform |
| Jul-01-25 | Initiated | Goldman | Buy |
| Jul-01-25 | Initiated | JP Morgan | Overweight |
| Jul-01-25 | Initiated | Morgan Stanley | Overweight |
| Jul-01-25 | Initiated | Needham | Buy |
View All
Omada Health Inc Stock (OMDA) Latest News
Omada Health's (OMDA) Sell (D) Rating Reaffirmed at Weiss Ratings - MarketBeat
Omada Health’s Digital Care Bet Outpaces Wall Street Expectations - Finimize
Omada Health, Inc. (NASDAQ:OMDA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Omada Health (NASDAQ:OMDA) Trading Up 7.6%Time to Buy? - MarketBeat
United States Digital Therapeutics Market Trends & Forecast | - openPR.com
Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients - HIT Consultant
Omada Health Launches 'Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting - The Manila Times
Beyond Calorie Counting: Omada Health's New AI Meal Map Revolutionizes Digital Nutrition Guidance - Stock Titan
Omada Health, Inc. (NASDAQ:OMDA) Receives $24.50 Consensus PT from Analysts - MarketBeat
Omada Health: Multiple Indicators Convince Me The Growth Outlook Remains Healthy - Seeking Alpha
Omada Health (NASDAQ:OMDA) Stock Price Down 5.9%Here's What Happened - MarketBeat
Omada Health (NASDAQ:OMDA) Upgraded to Hold at Baird R W - MarketBeat
Omada simplifies and accelerates IGA deployment while lowering total cost of ownership - Yahoo Finance
United States 7MM Digital Therapeutics for Diabetes Market - openPR.com
How Does Omada Health Stack Up After a 26% Share Price Surge? - Yahoo Finance
New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions - Yahoo Finance
Just 0.8% Weight Change: Omada Health's Groundbreaking Study Challenges Post-GLP-1 Weight Regain Assumptions - Stock Titan
Omada Health Develops Threat Model to Assess AI Risks in Healthcare - geneonline.com
Omada Health, Inc.(NasdaqGS: OMDA) added to NASDAQ Composite Index - MarketScreener
Baird initiates coverage on Omada Health stock with Neutral rating By Investing.com - Investing.com Australia
Omada Health shares fall 2.23% intraday after Baird initiates coverage with a Neutral rating and $24 price target. - AInvest
Baird Initiates Omada Health at Neutral With $24 Price Target - MarketScreener
Baird initiates coverage on Omada Health stock with Neutral rating - Investing.com
Baird Initiates Omada Health(OMDA.US) With Hold Rating, Announces Target Price $24 - 富途牛牛
Heartflow, Inc. shares rise 2.21% premarket after new research from Omada Health demonstrates lower healthcare utilization and spending for patients using virtual physical therapy programs. - AInvest
Omada Health announce research on cost savings of virtual physical therapy - TipRanks
Omada Health Study Shows Virtual PT Saves on Medical Care and Costs. - AInvest
Omada Health Study Finds Virtual Physical Therapy Saves Significant Costs for Musculoskeletal Conditions - AInvest
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy - Yahoo Finance
$1,000+ Per Patient: Omada's Virtual Physical Therapy Outperforms Traditional Care in Major Cost Study - Stock Titan
Omada Health shares fall 1.75% premarket ahead of senior management's participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Heartflow, Inc. shares rise 2.87% premarket after Omada Health's senior management participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health shares rise 3.31% intraday after announcing participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health to Participate in Upcoming Investor Conference - Yahoo Finance
Virtual Healthcare Leader Omada Health to Present at Morgan Stanley's 23rd Global Healthcare Conference - Stock Titan
Omada Health, Inc. (NASDAQ:OMDA) Receives $24.57 Average PT from Brokerages - MarketBeat
Healthcare Analysts Bullish on CSL, UnitedHealth, and Omada Health - AInvest
Omada Health stock rises on market debut - MSN
U.S. Digital Therapeutics Market Positioned for Accelerated - openPR.com
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Visana Health Appoints Chief Commercial Officer to Drive New Growth - Business Wire
Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail
Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Omada grows revenue, membership in public earnings debut - Healthcare Dive
Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest
Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com Nigeria
Barclays raises Omada Health PT to $24, maintains Overweight rating. - AInvest
Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India
Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa
Omada Health Inc Stock (OMDA) Financials Data
There is no financial data for Omada Health Inc (OMDA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
8.35%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):